Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201
18 févr. 2014 07h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today successful results from a pilot bioequivalence study...
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201
05 déc. 2013 12h49 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pilot bioequivalence study in...